Lawyers in the second talc bankruptcy sparred on Wednesday over the possible reappointment of a future claims representative, whose role is critical to resolving all the cancer litigation against Johnson & Johnson through a Chapter 11 reorganization plan.
Johnson & Johnson subsidiary LTL Management, which filed for Chapter 11 last month, moved to reappoint Randi Ellis, who served as the future claims representative in its first bankruptcy before a federal appeals court threw the case out. As the future claims representative, Ellis was tasked with ensuring that the interests of individuals diagnosed with cancer in the future were considered when drafting a bankruptcy reorganization plan.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
